Sylphar
Sylphar is a privately held Belgian manufacturer founded in 2007 that produces medical aids and cosmetic products, employing 11–50 staff and operating under a full C-suite with backing from Vendis Capital since 2017.
- Company typePrivate
- Founded2007
- HeadquartersDeurle, Belgium
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Sylphar does
Sylphar is a privately held specialty manufacturer of medical aids and cosmetic products, headquartered in Deurle, Belgium, and founded in 2007. The company operates with a small workforce of 11–50 employees and maintains a dedicated C-suite (CEO Robin List, COO Koen Steyaert, CFO Patrick Baeyens, CMO Sabine De Prest), suggesting an organizational structure oriented toward branded consumer healthcare rather than commodity contract manufacturing.
The product portfolio spans two adjacent categories — medical aids (devices and support products for everyday health needs) and cosmetic products — sold through consumer-facing channels typical for European OTC and personal care brands. No specific SKU list, formulation technology, proprietary platform, or production technology is disclosed in the source material; the company's underlying technical differentiation, if any, cannot be characterized beyond its positioning at the intersection of medical aids and beauty/personal care.
On the commercial side, Sylphar's business model is consistent with branded consumer health: revenue is generated through unit sales of manufactured medical aids and cosmetic products via retail, pharmacy, and/or direct channels (specific channel mix is not disclosed). The company received a 2017 funding event led by Vendis Capital, a consumer-healthcare-focused private equity firm, indicating institutional sponsorship typical of European specialty health platforms pursuing organic growth and/or bolt-on M&A. The input also contains extensive data on Karo Healthcare, a separate much larger Swedish branded healthcare company; that data set does not describe Sylphar and should not be conflated with the analysis of this company.
Sylphar firmographics
Firmographics- Name
- Sylphar
- Legal name
- Karo Healthcare AB
- Website
- https://sylphar.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sylphar is a privately held Belgian manufacturer founded in 2007 that produces medical aids and cosmetic products, employing 11–50 staff and operating under a full C-suite with backing from Vendis Capital since 2017.
- Ownership category
- akta.pro rank
Sylphar industry classification
Industry- Product category
- Medical Aids and Cosmetics Manufacturing
- NAICS
- Toilet Preparation Manufacturing (32562)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Feminine Hygiene & Intimate Care (Wash, Wipes, Deodorants) (CRADANAG)
- akta.pro secondary industry
- Foot Care (Deodorizing, Anti-chafe, Callus Care) (CRADANAK)
Keywords
Where Sylphar is headquartered
LocationHeadquarters
- HQ city
- Deurle
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
Sylphar business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales
Revenue model
- Branded healthcare product sales: Karo Healthcare owns and commercialises a range of documented and trusted brands within key categories of everyday healthcare including Digestive Health, Foot Health, Skin Health, Vitamins & Mineral Supplements, Intimate Health, and Pain Relief. Revenue generated through product sales across 90+ markets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Sylphar product offering
Product offeringCore offering
Sylphar manufactures medical aids and cosmetic products. The company is a Belgium-based producer focused on physical goods in the medical aids and personal care categories. Detailed product line listings, brand names, and SKUs are not provided in the available source data.
Product overview
Karo Healthcare is a pharmaceutical/healthcare company operating a multi-brand portfolio strategy, owning and commercializing documented and trusted brands across key everyday healthcare categories including Digestive Health (Proct), Foot Health (Lamisil), Skin Health (E45), Vitamins & Mineral Supplements (Nutravita), Intimate Health (Multi-Gyn), oral care (Flux), and pain relief (Paracet). The company also owns Remescar and Pevaryl brands. These brands are organized around the core concept of 'Smart Choices for Everyday Healthcare,' with products available in over 90 countries. The portfolio is structured around cross-functional 'squad teams' that each work with a specific brand or category, reflecting a scaled entrepreneurship operating model.
Differentiator
Problem solved
Functional benefit
Brands
- Proct: Digestive Health
- Lamisil
- E45
- Nutravita
- Remescar
- Pevaryl
- Flux
- Multi-Gyn
- Paracet
Products and services
- Medical aids Medical aids manufactured by Sylphar for consumer use.
- Cosmetic products Cosmetic products manufactured by Sylphar for consumer use.
Quantifiable outcome
- 150 new products launched in 2023
Companies that use Sylphar
Customer profileSegments6 records
Ideal customer profiles1 record
Sylphar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sylphar partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Operation SmilecoreKaro Healthcare has supported Operation Smile since 2018. Operation Smile performs about 15,000 surgeries per year to improve the lives of children born with cleft lip or palate. This partnership aligns with Karo's purpose of creating smart choices for everyday healthcare and corporate responsibility.
Scale indicators6 records
Recent moves2 records
Expansion highlights3 records
Sylphar competitors and assessment
Company assessmentBroad incumbents
- Bayer Consumer Health: A large global consumer-health incumbent with overlapping categories (skin health, foot care, pain relief) that competes with Sylphar through established brands at much greater scale and broader distribution.
- Haleon: A global consumer healthcare giant (spun out of GSK) with multi-billion-dollar OTC/personal-care brands across oral health, skin health, and pain relief — directly overlapping Sylphar's medical-aids/cosmetic product space and the most relevant large-cap incumbent comparable.
- Stada Arzneimittel: A European generics and consumer healthcare company that owns a portfolio of OTC and personal-care brands across the same categories Sylphar serves, including foot care and dermatology.
Direct peers
- Sebapharma: A German personal-care manufacturer with a portfolio spanning body care, foot care, and dermatological cosmetics, comparable to Sylphar in product mix and EU-centric pharmacy distribution.
- Urgo Healthcare: A French dermo-cosmetic and medical-aids manufacturer whose product range (wound/skin care, intimate care, foot care) closely mirrors Sylphar's stated scope of medical aids and cosmetic products.
- Pierre Fabre Dermatologie: A French dermo-cosmetic specialist commercializing skincare and personal care brands through pharmacy channels in Europe, directly comparable to Sylphar's positioning as a medical-aid/cosmetic-product manufacturer in the EU.
- HRA Pharma: A European consumer healthcare company focused on OTC and personal-care niches, including intimate health and dermatology-adjacent categories that overlap with Sylphar's medical-aids and cosmetic products mix.
- Ducray (Laboratoires Dermatologiques Ducray): A French dermo-cosmetic brand focused on dermatological skincare and haircare sold largely through European pharmacies — comparable in product category and distribution logic to Sylphar's offering.
- Cooper Consumer Health: A European-focused multi-brand OTC and personal-care platform that owns and commercializes brands across foot health, intimate health, skin health, and pain relief — the same brand-house model that Sylphar's 'medical aids and cosmetic products' positioning implies.
Regional players
- Omega Pharma: A Belgian OTC and personal care platform with comparable product categories (foot care, intimate care, dermo-cosmetics) and same Belgian/Western European geographic base, making it the closest direct regional comparable for Sylphar.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Sylphar social profiles
Digital presenceSylphar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sylphar leadership team
Management profileNumber of profiles
Profiles4 records
Sylphar funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sylphar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sylphar
What does Sylphar do?
Sylphar manufactures medical aids and cosmetic products. The company is a Belgium-based producer focused on physical goods in the medical aids and personal care categories. Detailed product line listings, brand names, and SKUs are not provided in the available source data.
Is Sylphar a public or private company?
Sylphar is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sylphar founded?
Sylphar was founded in 2007. It employs 11 to 50 people.
Where is Sylphar based?
Sylphar is headquartered in Deurle, Belgium, in the Europe region.
How does Sylphar make money?
One revenue line is on record: branded healthcare product sales.
Who are Sylphar's main competitors?
Broad incumbents on record are Bayer Consumer Health, Haleon and Stada Arzneimittel. Direct peers are Sebapharma, Urgo Healthcare, Pierre Fabre Dermatologie, HRA Pharma, Ducray (Laboratoires Dermatologiques Ducray) and Cooper Consumer Health. Omega Pharma is listed as a regional player.
Does Sylphar have an API?
No public API is recorded for Sylphar.
What industry is Sylphar in?
Sylphar's product category is Medical Aids and Cosmetics Manufacturing. Its primary akta.pro industry code is CRADANAG, Feminine Hygiene & Intimate Care (Wash, Wipes, Deodorants), with a secondary code of CRADANAK, Foot Care (Deodorizing, Anti-chafe, Callus Care). Its NAICS code is 32562 and its SIC code is 2844.